Advanced search
Publication Cover
mAbs Volume 12, 2020 - Issue 1
Submit an article Journal homepage
5,936
Views
21
CrossRef citations to date
0
Altmetric
Report

VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis

Sarah Lowa Biotherapeutics Molecule Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAORCID Iconhttps://orcid.org/0000-0001-7587-6435
ORCID Icon,
Haixia Wua Biotherapeutics Molecule Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Kavita Jeratha Biotherapeutics Molecule Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Annette Tibollab Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Birgit Fogalb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAORCID Iconhttps://orcid.org/0000-0002-1682-7729
ORCID Icon,
Rebecca Conradb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Deborah Webbc Immunology and Respiratory Diseases, Boehringer Ingelheim Pharmaceuticals Inc
,
Margit MacDougallb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Steven Kerrb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Valentina Bergerb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAORCID Iconhttps://orcid.org/0000-0001-9597-3638
ORCID Icon,
Rajvee Daveb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Jorge Villalonab Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Lynn Pantagesb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Jennifer Ahlbergd Biotherapeutics Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAORCID Iconhttps://orcid.org/0000-0002-2892-4163
ORCID Icon,
Hua Lid Biotherapeutics Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Diane Van Hooricke Project Management, Ablynx a Sanofi Company, Zwijnaarde, Belgium
,
Cedric Ververkene Project Management, Ablynx a Sanofi Company, Zwijnaarde, Belgium
,
John Broadwaterb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Alisa Watermanb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
,
Sanjaya Singha Biotherapeutics Molecule Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAORCID Iconhttps://orcid.org/0000-0002-9119-7966
ORCID Icon &
Rachel Kroe-Barretta Biotherapeutics Molecule Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1413-1223
ORCID Icon show all
Article: 1709322 | Received 27 Aug 2019, Accepted 20 Dec 2019, Published online: 10 Jan 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.